Successful Treatment of Statin Resistant Hypercholesterolemia by an Inhibitor of Cholesterol Absorption, Ezetimibe

Yoshitaka Maeda, Yuya Araki, Tomomi Uno, Keisuke Nishigaki, Naoto Inaba

Abstract


HMG-CoA reductase inhibitors (statins) are frequently prescribed against hypercholesterolemia, and these agents successfully suppress levels of serum LDL-cholesterol in most cases. We experienced a case of hypercholesterolemia resistant to statins, but well responsive to an inhibitor of cholesterol absorption in the intestine, ezetimibe. The case was a 58-year-old, non-obese female with persistent high-levels of LDL-cholesterol (LDL-Cho) around 200 (193 - 204) mg/dl even after administration of statins, pitavastatin or rosuvastatin. An inhibitor of cholesterol absorption, ezetimibe was added to rosuvastatin, which resulted in lowering serum LDL-Cho levels to 90 mg/dl. The actual reduction rate of LDL-Cho was 5.4% by rosuvastatin alone, and this rate was up to 53.4% by adding ezetimibe. These results suggest that enhanced cholesterol absorption, rather than cholesterol synthesis, caused hypercholesterolemia in this case. Cholesterol absorption is accelerated in some diseases or conditions, such as diabetes mellitus and obesity, both of which were not identified in this case. Unknown genetic or acquired abnormalities in the intestinal cholesterol-transporting system may be involved in developing hypercholesterolemia. Hence, suppression of cholesterol absorption is a considerable option for hypercholesterolemia resistant to statins.




J Med Cases. 2011;2(2):44-47
doi: https://doi.org/10.4021/jmc124w


Keywords


HMG CoA reductase; NPC1L1; Cholestanol

Full Text: HTML PDF
 

Browse  Journals  

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.